NCT02446652 2025-05-29
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
National Institute of Cancerología
Phase 3 Withdrawn
National Institute of Cancerología
Instituto Nacional de Cancerologia, Columbia
Sheba Medical Center